Journal of Cardiovascular Disease Research
A PROSPECTIVE OBSERVATIONAL STUDY ON ESTIMATION OF RISK FOR MAJOR ADVERSE CARDIAC EVENTS IN ACUTE CORONAY SYNDROME UNDERGOING PERCUTANEOUS CORONARY INTERVENTION
Dr. Kavya Pingali
JCDR. 2023: 1734-1747
Abstract
Introduction: In worldwide, Cardiovascular disease has a considerable impact on morbidity and mortality. According to the WHO, 17.9 million people died from cardiovascular diseases in 2019, accounting 32% of global mortality. Acute coronary syndrome (ACS), which includes ST-segment elevated myocardial infarction (STEMI), non-STEMI, unstable angina (UA), is the most significant contributor to cardiovascular disease. Percutaneous coronary intervention (PCI) is a minimally invasive, non-surgical method used to treat coronary artery occlusion and enhance blood flow to ischemic tissue. A Major Adverse Cardiovascular Event (MACE) in the setting of PCI has been characterized as death, Myocardial Infarction (MI), repeat revascularization with bypass graft. Thrombolysis in Myocardial Infarction (TIMI) score and Global Registry for Acute Coronary Events (GRACE) score are used to predict the risk of mortality in ACS patient.
» PDF